Stem cell-based approaches to treating HIV infection.
OBJECTIVE
Stem cell-based strategies for treating HIV-infected individuals represent a novel approach toward reconstituting the ravaged immune system with the ultimate aim of clearing the virus from the body. Genetic modification of human hematopoietic stem cells to produce cells that are either resistant to infection, cells that produce lower amounts of infectious virus, or cells that specifically target the immune response against the virus are currently the dominant strategies under development. This review focuses on the understanding of stem cell-based approaches that are under investigation and the rationale behind such approaches.


RESULTS
Significant progress has recently been made utilizing stem cell-based approaches to treat HIV infection. Ideally, a successful strategy would result in immune clearance of the virus from the body as well long-term restoration of overall immune responses to successfully combat everyday environmental antigens. Two recent clinical trails illustrate how new advances in stem cell-based approaches may propel this field forward to clinical reality: one that demonstrates that large-scale gene therapy trials can be performed in a conventional, reproducible manner; and one that demonstrates the utilization of a multipronged approach using lentiviral-based gene therapy vectors. These clinical trails serve as the foundation for the development of other technologies, discussed here, that are currently in preclinical development.


CONCLUSIONS
Recent advances using stem cell-based approaches to treat HIV infection have provided the impetus for a renewed and expanded interest in the development of new cell-based strategies to treat HIV infection as well as a variety of other diseases.
Division of Hematology/Oncology, Department of Medicine, The UCLA AIDS Institute, Los Angeles, California, USA.
Scott G
SG
Kitchen
Jerome A
JA
Zack
D015658:HIV Infections / Q000276:immunology / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000502:physiology* / Q000821:virology; D006801:Humans; D007113:Immunity, Innate
J Virol. 2008 Mar;82(6):3078-89
18184707
Blood. 2001 Jun 1;97(11):3484-90
11369641
Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11742-7
16844782
Nat Med. 1996 Nov;2(11):1240-3
8898752
Immunity. 2010 Jun 25;32(6):737-42
20620940
PLoS One. 2008 Jul 23;3(7):e2747
18648518
Nat Med. 1997 Mar;3(3):252-3
9055842
Lancet Infect Dis. 2006 May;6(5):280-7
16631548
Nature. 1996 Aug 22;382(6593):722-5
8751444
J Virol. 2000 Sep;74(17):8207-12
10933734
J Gene Med. 2008 Oct;10(10):1059-70
18642399
J Virol. 1998 Jul;72(7):6040-7
9621067
Curr Med Chem. 2006;13(23):2725-36
17073624
Curr Opin HIV AIDS. 2009 Mar;4(2):96-103
19339947
Cell. 2009 Jul 10;138(1):30-50
19596234
N Engl J Med. 2009 Feb 12;360(7):692-8
19213682
Blood. 2010 Nov 11;116(19):3818-27
20660788
Nature. 2008 Jan 10;451(7175):141-6
18157115
AIDS. 1999 Feb 25;13(3):433-4
10199243
JAMA. 2010 Apr 28;303(16):1617-24
20424252
J Stem Cells. 2009;4(1):29-45
20498689
Lancet. 1997 Apr 26;349(9060):1219-20
9130946
Lancet. 1997 Apr 26;349(9060):1219
9130945
J Virol. 2010 Jul;84(13):6645-53
20410262
Nat Rev Immunol. 2008 Apr;8(4):247-58
18323851
Science. 1996 Sep 27;273(5283):1856-62
8791590
Blood. 2009 Feb 12;113(7):1422-31
19059876
AIDS. 1997 Aug;11(10):F67-71
9256936
J Exp Med. 1993 Sep 1;178(3):1067-76
8102389
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2883-8
18287077
Proc Natl Acad Sci U S A. 2002 May 14;99(10):7015-20
12011460
J Virol. 1999 Oct;73(10):7972-80
10482544
Lancet Infect Dis. 2010 Apr;10(4):251-61
20334848
Trends Immunol. 2010 Mar;31(3):120-30
20089450
J Acquir Immune Defic Syndr. 2002 Mar 1;29(3):307-13
11873082
Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8727-32
15173593
Sci Transl Med. 2010 Jun 16;2(36):36ra43
20555022
J Exp Med. 2009 Jun 8;206(6):1253-72
19487423
Clin Infect Dis. 2009 Mar 15;48(6):787-94
19193107
Nat Biotechnol. 2010 Aug;28(8):839-47
20601939
Blood. 1994 Nov 15;84(10):3344-55
7524737
J Virol. 2004 Feb;78(3):1160-8
14722271
Hum Gene Ther. 2008 Jun;19(6):622-34
18533892
Stem Cells. 2009 Jan;27(1):100-7
18974209
Cell. 1985 Aug;42(1):93-104
2990730
Blood. 1994 Nov 1;84(9):2878-89
7949163
Nat Med. 2009 Mar;15(3):285-92
19219022
J Exp Med. 1989 Jan 1;169(1):327-32
2783333
Nature. 2010 Mar 11;464(7286):217-23
20220840
J Immunol Methods. 1990 Dec 31;135(1-2):59-69
1703191
J Virol. 2002 Apr;76(7):3114-24
11884536
Cell. 2007 Nov 30;131(5):861-72
18035408
Science. 2009 Mar 27;323(5922):1726-9
19325114
AIDS Res Ther. 2008 Jan 23;5:1
18215326
Nat Rev Immunol. 2008 Aug;8(8):619-30
18617886
Genet Vaccines Ther. 2009 Jun 10;7:8
19515239
Blood. 2003 Jun 1;101(11):4452-6
12531788
J Virol. 2009 Aug;83(15):7641-8
19458000
J Virol. 1991 Feb;65(2):736-42
1702842
Blood. 2010 Feb 25;115(8):1534-44
20018916
Nat Med. 2008 Dec;14(12):1390-5
18997777
PLoS One. 2009 Dec 07;4(12):e8208
19997617
Retrovirology. 2006 Apr 19;3:24
16623949
Blood. 1997 Feb 15;89(4):1364-75
9028960
J Immunol. 2009 Jun 1;182(11):6879-88
19454684
Lancet. 2002 May 25;359(9320):1832-4
12044382
Nat Biotechnol. 2007 Dec;25(12):1444-54
18066041
Nat Med. 2010 Apr;16(4):446-51
20208541
Science. 2007 Dec 21;318(5858):1917-20
18029452
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11478-83
9326635